Description of the first Escherichia coli clinical isolate harboring the colistin resistance gene mcr-1 from the Indian subcontinent

Antimicrobial Agents and Chemotherapy

Volumn 61, Issue 1, 2017, Pages

  Mohsin, Mashkoor ^a   Raza, Shahbaz ^a   Roschanski, Nicole ^b   Guenther, Sebastian ^b   Ali, Aamir ^c,d   Schierack, Peter ^c  

^a UNIVERSITY OF AGRICULTURE   (Pakistan)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c BRANDENBURG UNIVERSITY OF TECHNOLOGY   (Germany)

^d NATIONAL INSTITUTE FOR BIOTECHNOLOGY AND GENETIC ENGINEERING NIBGE   (Pakistan)

Author keywords

CTX M 15; ESBL; IncI2; Indian subcontinent; mcr 1; Polymyxins

Indexed keywords

AMIKACIN; AZTREONAM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; FOSFOMYCIN; GENTAMICIN; IMIPENEM; MARBOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; SODIUM AZIDE; TETRACYCLINE; TIGECYCLINE; TOBRAMYCIN; ANTIINFECTIVE AGENT; ESCHERICHIA COLI PROTEIN; MCR-1 PROTEIN, E COLI;

ADULT; ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BACTERIUM ISOLATE; CASE REPORT; CONJUGATION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; HUMAN; LETTER; MALE; MIGRANT BIRD; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHENOTYPE; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; DRUG EFFECT; ESCHERICHIA COLI; GENETICS; METABOLISM;

ANTI-BACTERIAL AGENTS; COLISTIN; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; PLASMIDS;

EID: 85009291681     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01945-16     Document Type: Letter

References (7)

1. Liu Y-Y, Wang Y, Walsh TR, Yi L-X, Zhang R, Spencer J, Doi Y, Tian G, Dong B, Huang X, Yu L-F, Gu D, Ren H, Chen X, Lv L, He D, Zhou H, Liang Z, Liu J-H, Shen J. 2016. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 16:161-168. https://doi.org/10.1016/S1473-3099(15)00424-7.
2. Castanheira M, Griffin MA, Deshpande LM, Mendes RE, Jones RN, Flamm RK. 2016. Detection of mcr-1 among Escherichia coli clinical isolates collected worldwide as part of the SENTRY Antimicrobial Surveillance Program in 2014 and 2015. Antimicrob Agents Chemother 60:5623-5624. https://doi.org/10.1128/AAC.01267-16.
3. Irrgang A, Roschanski N, Tenhagen B-A, Grobbel M, Skladnikiewicz-Ziemer T, Thomas K, Roesler U, Kasbohrer A. 2016. Prevalence of mcr-1 in E. coli from livestock and food in Germany, 2010-2015. PLoS One 11:e0159863. https://doi.org/10.1371/journal.pone.0159863.
4. Ewers C, Grobbel M, Stamm I, Kopp PA, Diehl I, Semmler T, Fruth A, Beutlich J, Guerra B, Wieler LH, Guenther S. 2010. Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-beta-lactamase-producing Escherichia coli among companion animals. J Antimicrob Chemother 65:651-660. https://doi.org/10.1093/jac/dkq004.
5. Schaufler K, Wieler LH, Semmler T, Ewers C, Guenther S. 2013. ESBL-plasmids carrying toxin-antitoxin systems can be "cured" of wild-type Escherichia coli using a heat technique. Gut Pathog 5:34. https://doi.org/10.1186/1757-4749-5-34.
6. Mohsin M, Raza S, Roschanski N, Schaufler K, Guenther S. 2016. First description of plasmid-mediated colistin-resistant extended-spectrum β-lactamase-producing Escherichia coli in a wild migratory bird from Asia. Int J Antimicrob Agents 48:463-464. https://doi.org/10.1016/j.ijantimicag.2016.07.001.
7. Wirth T, Falush D, Lan R, Colles F, Mensa P, Wieler LH, Karch H, Reeves PR, Maiden MC, Ochman H, Achtman M. 2006. Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol 60:1136-1151. https://doi.org/10.1111/j.1365-2958.2006.05172.x.